Business · 17/02/2006Updated: 10/17/2026 · 1 min read
FDA Releases Guidance on Waivers for Animal Drug Bioequivalence in Soluble Powder Oral Dosage Form Products
Summary
The Food and Drug Administration (FDA) has made available a guidance document outlining procedures for reviewing requests to waive in vivo bioequivalence testing for generic soluble powder oral dosage form products and Type A medicated articles.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →